• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

About FDA

  • Print
  • Share
  • E-mail

SMG 1264.51

FDA STAFF MANUAL GUIDES, VOLUME I - ORGANIZATIONS AND FUNCTIONS

FOOD AND DRUG ADMINISTRATION

CENTER FOR DRUG EVALUATION AND RESEARCH

OFFICE OF TESTING AND RESEARCH

DIVISION OF DRUG SAFETY RESEARCH

Effective Date: 02/25/2011

[PDF Version]

1. DIVISION OF DRUG SAFETY RESEARCH (DBNSDA).

A. Provides expert advice to the drug review divisions and other scientific and regulatory units of the Center on preclinical and clinical aspects of pharmacology, toxicology, and the mechanisms underlying drug absorption, metabolism, transport, distribution and excretion.

B. Plans and conducts non-clinical research to investigate the mechanisms of drug-induced injury, and to assess the utility of diverse laboratory models, methods, assays and biomarkers in accurately predicting the clinical effects of drug product.

C. Conducts research to understand drugs in the context of their clinical use, based on the study of pharmacokinetics, drug metabolism and transport, pharmacogenomics, drug monitoring and effects in special populations.

D. Devises, qualifies and validates laboratory methods and endpoints intended to establish a better understanding of drug exposure levels, patient response and potential drug safety issues, and to relieve critical rate-limiting steps in the drug development process.

E. Develops non-clinical model systems and data analysis approaches that can assist in speeding the initiation of clinical trials.

F. Designs, executes and collaborates in studies intended to translate non-clinical findings to the clinical setting.

G. Collaborates with the Office of Translational Science, Office of New Drugs and other Center Offices and Divisions on research supporting their regulatory missions.

H. Collaborates in joint projects with other Government Agencies in projects that support the goals and mission of the Center.

2. AUTHORITY AND EFFECTIVE DATE.

The functional statements for this Division were approved by the Commissioner of Food and Drugs, effective February 25, 2011.

STATUS
(I, R, C)
DATE APPROVEDLOCATION
OF CHANGE HISTORY
CONTACTAPPROVING OFFICIAL
Initial05/04/2010N/aOC/OA/
OFO/OFM
William Collinson, Director, OFM
Revision02/25/2011N/aOC/OA/
OM/OMP
Commissioner of Food and Drugs